US Government to Start Imposing Inflation Penalties on Drugmakers in 2025

The US government will begin imposing penalties in 2025 on drug companies that charge its Medicare program prices that rise faster than inflation, the Centers for Medicare & Medicaid Services said on Thursday.
Reuters Health Information

source https://www.medscape.com/viewarticle/988114?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?